GB/T 44138-2024 Active National standards

GB/T 44138-2024 Cardiovascular implants—Cardiovascular absorbable implants

GB/T 44138-2024 Cardiovascular implants—Cardiovascular absorbable implants

Publish Date: 2024-06-29 Implement Date: 2025-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: GB/T 44138-2024
Standard Type: National standards
Standard Status: Active
is_force_gb: no
CCS Name: Medical devices
ICS Name: Surgical implants, prostheses, and orthoses
Publish Date: 2024-06-29
Implement Date: 2025-07-01
Pages: 40 pages

Scope

This document specifies the general principles and requirements for the design evaluation of absorbable cardiovascular implants used to treat blood vessels and/or vascular regions (including the heart and the entire circulatory system). This document can be used as a supplement to specific device standards. This document applies to implants that come into direct contact with the cardiovascular system and are intended to function in the circulatory system. Note 1: Certain aspects of the absorbable components of cardiovascular drug-device combination products (such as coatings) are related to the content of the drug and are described in GB/T 39381.1. Note 2: The interpretation of absorbable, degradable, and related terms is provided in Appendix A. Note 3: This document does not specifically evaluate issues related to living tissues, living cells, and/or implants containing non-living biological materials and their derivatives. Additionally, procedures and devices used before and after the implantation of cardiovascular absorbable implants (such as balloon angioplasty devices) are not within the scope of this document if they do not affect the absorption of the implants. Absorbable cardiovascular implants may contain substances that can be considered pharmaceutical products (drugs) when used alone, but the drug effect is auxiliary to the implant and supports the main mode of action of the implant.

Development Information

Word Count: 60 Thousand words Pages: 40 pages

Referenced Standards

GB/T 16886.23-2023 Biological evaluation of medical devices—Part 23:Tests for irritation GB 18278.1-2015 Sterilization of health care products—Moist heat—Part 1:Requirements for the development, validation and routine control of a sterilization process for medical devices GB 18279.1-2015 Sterilization of health care products—Ethylene oxide—Part 1:Requirements for development,validation and routine control of a sterilization process for medical devices GB 18280.1-2015 Sterilization of health care products—Radiation—Part 1:Requirements for development,validation and routine control of a sterilization process for medical devices GB 18280.1-2025 Sterilization of health care products—Radiation—Part 1:Requirements for the development,validation and routine control of a sterilization process for medical devices GB 18280.2-2015 Sterilization of health care products—Radiation—Part 2:Establishing the sterilization dose GB/T 18280.2-2025 Sterilization of health care products—Radiation—Part 2:Establishing the sterilization dose GB/T 18280.3-2015 Sterilization of health care products—Radiation—Part 3:Guidance on dosimetric aspects GB/T 18280.3-2025 Sterilization of health care products—Radiation—Part 3:Guidance on dosimetric aspects of development,validation and routine control GB/T 19633.1-2015 Packaging for terminally sterilized medical devices—Part 1:Requirements for materials, sterile barrier systems and packaging systems GB/T 19633.1-2024 Packaging for terminally sterilized medical devices—Part 1:Requirements for materials,sterile barrier systems and packaging systems GB/T 19974-2005 Sterilization of health care products—General requirement for characterization of a sterilization agent and the development, validation and routine control of a sterilization process for medical devices GB/T 19974-2018 Sterilization of health care products—General requirement for characterization of a sterilization agent and the development, validation and routine control of a sterilization process for medical devices GB/T 39381.1-2020 Cardiovascular implants—Vascular device-drug combination products—Part 1:General requirements YY/T 0316-2003 Medical devices—Application of risk management to medical devices YY/T 0316-2008 Medical devices—Application of risk management to medical devices YY/T 0316-2016 Medical devices—Application of risk management to medical devices YY/T 0316-2000 YY/T 0316-2000 Medical devices - Risk analysis - Part 1: Application of risk analysis YY/T 0640-2016 Non-active surgical implants—General requirements YY/T 0663-2008 Non active surgical implants—Particular requirements for cardiac and vascular implants—Specific requirements for arterial stents YY/T 0663.1-2014 Cardiovascular implant—Endovascular devices—Part 1:Endovascular prostheses YY/T 0663.1-2021 Cardiovascular implants—Endovascular devices—Part 1:Endovascular prostheses YY/T 0663.2-2016 Cardiovascular implants Endovascular devices—Part 2:Vascular stents YY/T 0663.2-2024 Cardiovascular implants—Endovascular devices—Part 2:Vascular stents YY/T 0663.3-2016 Cardiovascular implants—Endovascular devices—Part 3:Vena cava filters YY/T 1449.3-2016 Cardiovascular implants—Cardiac valve prostheses—Part 3:Heart valve substitutes implanted by transcatheter techniques YY/T 1775.1-2021 Biological evaluation of absorbable medical devices—Part 1:Guidance for absorbable implants

Adopt standards

ISO/TS 17137:2021

Related Standards

Contact Us